
|Videos|May 24, 2017
Role of Stereotactic Ablative Radiotherapy in Early-Stage Lung Cancer
Author(s)Alexander Louie, MD, PhD, MSc
This video examines the role of radiation therapy in early-stage lung cancer and some of the data comparing stereotactic ablative radiotherapy vs surgery in these patients.
Advertisement
In this video Alexander Louie, MD, PhD, MSc, of the London Health Sciences Centre in Canada, discusses the role of stereotactic ablative radiotherapy (SABR) in early-stage lung cancer patients who are not eligible for surgery, some of the literature about late effects of radiotherapy, and data comparing SABR vs surgery.
Louie gave a presentation on this topic at the 2017 Multidisciplinary Thoracic Cancers Symposium.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
3
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
4
Selinexor Combo Improves Spleen Volume Reduction in Myelofibrosis
5























































